Clinical Application of Wearable Magnet Tracking System for Capsule Endoscopes
1 other identifier
interventional
10
1 country
1
Brief Summary
The investigators developed a wearable magnet tracking system, which provided a non-invasive and high accuracy method for capsule endoscopes localization. Data fusion from multiple sensors expanded positioning range and proposed localization algorithm overcame shortcomings of existing systems. This clinical trial was conducted to verify effectiveness and stability of the tracking system.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 15, 2022
CompletedFirst Posted
Study publicly available on registry
September 19, 2022
CompletedStudy Start
First participant enrolled
March 30, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2025
CompletedOctober 18, 2024
October 1, 2024
2.6 years
September 15, 2022
October 16, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
The duration of time
the length of time of the tracking system used in continuous acquisition of the magnetic field strength values
12 months
Study Arms (1)
wearable magnet tracking system
EXPERIMENTALInterventions
In this group, wearable magnet tracking system was used.
Eligibility Criteria
You may qualify if:
- aged between 18 and 75
- agree to give written informed consent
You may not qualify if:
- dysphagia or symptoms of gastric outlet obstruction, suspected or known intestinal stenosis, overt gastrointestinal bleeding, history of upper gastrointestinal surgery or abdominal surgery altering gastrointestinal anatomy, or postabdominal radiation
- congestive heart failure, renal insufficiency, under therapeutic anticoagulation, in poor general condition (American Society of Anesthesiologists class III/IV), claustrophobia, metallic parts, a pacemaker or other implanted electromedical devices, or artificial heart valves
- pregnancy or suspected pregnancy
- currently participating in another clinical study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Qilu Hospital of Shandong University
Jinan, Shandong, China
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 15, 2022
First Posted
September 19, 2022
Study Start
March 30, 2023
Primary Completion
October 30, 2025
Study Completion
October 30, 2025
Last Updated
October 18, 2024
Record last verified: 2024-10